N2,N2-dimethyl-5-phenyl-N4-(pyridin-2-ylmethyl)quinazoline-2,4-diamine

ID: ALA4441179

Chembl Id: CHEMBL4441179

PubChem CID: 155515076

Max Phase: Preclinical

Molecular Formula: C22H21N5

Molecular Weight: 355.45

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1nc(NCc2ccccn2)c2c(-c3ccccc3)cccc2n1

Standard InChI:  InChI=1S/C22H21N5/c1-27(2)22-25-19-13-8-12-18(16-9-4-3-5-10-16)20(19)21(26-22)24-15-17-11-6-7-14-23-17/h3-14H,15H2,1-2H3,(H,24,25,26)

Standard InChI Key:  VNUXXZPZCAHSMA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4441179

    ---

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNA5 Tclin Voltage-gated potassium channel subunit Kv1.5 (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 355.45Molecular Weight (Monoisotopic): 355.1797AlogP: 4.37#Rotatable Bonds: 5
Polar Surface Area: 53.94Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.41CX LogP: 4.51CX LogD: 4.47
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.58Np Likeness Score: -1.30

References

1. Finlay HJ, Johnson JA, Lloyd JL, Jiang J, Neels J, Gunaga P, Banerjee A, Dhondi N, Chimalakonda A, Mandlekar S, Conder ML, Sale H, Xing D, Levesque P, Wexler RR..  (2016)  Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur Inhibitor.,  (9): [PMID:27660686] [10.1021/acsmedchemlett.6b00117]

Source